Paper32039434
Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion.
Ouzon-Shubeita H and 2 others. Biochem J, 2020. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion. Papers, record 32039434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32039434
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cisplatin | Major topic |
| DNA Damage | Major topic |
| DNA-Directed DNA Polymerase | Major topic |
| Mutagenesis | Major topic |
| Crystallography, X-Ray | |
| Humans | |
| Protein Structure, Secondary |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 CA243349 | NCI NIH HHS | United States | F31CA243349 | PubMed and NIH | NIH RePORTER |
| R01 ES026676 | NIEHS NIH HHS | United States | R01ES026676 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10357787 | DNA polymerase beta expression differences in selected human tumors and cell lines. | Carcinogenesis | 1999 | https://conductscience.org/library/papers/10357787 | PubMed |
| 2 | 22315190 | Stereospecific formation of a ternary complex of (S)-α,β-fluoromethylene-dATP with DNA pol β. | Chembiochem | 2012 | https://conductscience.org/library/papers/22315190 | PubMed |
| 3 | 8663082 | In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8663082 | PubMed |
| 4 | 30208165 | DNA repair pathways and cisplatin resistance: an intimate relationship. | Clinics (Sao Paulo) | 2018 | https://conductscience.org/library/papers/30208165 | PubMed |
| 5 | 10336894 | Overexpression of DNA polymerase beta: a genomic instability enhancer process. | FASEB J | 1999 | https://conductscience.org/library/papers/10336894 | PubMed |
| 6 | 11593426 | Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. | Oncogene | 2001 | https://conductscience.org/library/papers/11593426 | PubMed |
| 7 | 22529383 | Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22529383 | PubMed |
| 8 | 30817143 | Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA Polymerases. | J Am Chem Soc | 2019 | https://conductscience.org/library/papers/30817143 | PubMed |
| 9 | 10973926 | Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. | FASEB J | 2000 | https://conductscience.org/library/papers/10973926 | PubMed |
| 10 | 11827474 | Involvement of DNA polymerase beta in DNA replication and mutagenic consequences. | J Mol Biol | 2002 | https://conductscience.org/library/papers/11827474 | PubMed |
| 11 | 27161042 | A comprehensive survey of the mutagenic impact of common cancer cytotoxics. | Genome Biol | 2016 | https://conductscience.org/library/papers/27161042 | PubMed |
| 12 | 17625587 | The resurgence of platinum-based cancer chemotherapy. | Nat Rev Cancer | 2007 | https://conductscience.org/library/papers/17625587 | PubMed |
| 13 | 10769112 | Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. | Biochemistry | 2000 | https://conductscience.org/library/papers/10769112 | PubMed |
| 14 | 22659329 | Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. | Pharmacol Rev | 2012 | https://conductscience.org/library/papers/22659329 | PubMed |
| 15 | 25030888 | C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. | Genome Res | 2014 | https://conductscience.org/library/papers/25030888 | PubMed |
| 16 | 22178760 | Binary complex crystal structure of DNA polymerase β reveals multiple conformations of the templating 8-oxoguanine lesion. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22178760 | PubMed |
| 17 | 21068378 | Error-prone translesion synthesis mediates acquired chemoresistance. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/21068378 | PubMed |
| 18 | 2803953 | Cisplatin/carboplatin cross-resistance in ovarian cancer. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2803953 | PubMed |
| 19 | 12388548 | A role for DNA polymerase beta in mutagenic UV lesion bypass. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12388548 | PubMed |
| 20 | 29232469 | Acquired chemotherapy resistance in ovarian cancer. | Ann Oncol | 2017 | https://conductscience.org/library/papers/29232469 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40142039 | Structural Insights into the Nonmutagenicity of 2-Haloacetophenone. | Molecules | 2025 | https://conductscience.org/library/papers/40142039 | PubMed |
| 35603167 | Functionalized Lineage Tracing Can Enable the Development of Homogenization-Based Therapeutic Strategies in Cancer. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603167 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| LYZ | 4069 | PubTator's text mining | https://conductscience.org/library/genes/4069 | NCBI Gene |
| NEB | 4703 | PubTator's text mining | https://conductscience.org/library/genes/4703 | NCBI Gene |
| POLB | 5423 | PubTator's text mining | https://conductscience.org/library/genes/5423 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32039434
GET https://conductscience.org/api/papers/v1/32039434/references?page=2